Alnylam Pharmaceuticals Inc (ALNY) Stock Price, Quote, News & History

ALNYNASDAQ
$297.69
5.531.89%
Last update: Jun 9, 6:58 PM
$298.00
5.842.00%
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
714.90M
Investing Cash Flow (TTM)
297.02M
Financing Cash Flow (TTM)
-335.56M
Free Cash Flow (TTM)
643.34M
Capital Expenditure (TTM)
-71.56M
Net Change in Cash (TTM)
676.36M

Analyst Trends and Forecast

5
Feb
2
Mar
1
Apr
3
1
May
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$37.27B
PE Ratio (TTM)
73.41
PE Ratio (FWD)
31.25
PEG Ratio (TTM)
0.50
PS Ratio (TTM)
9.32
PB Ratio (TTM)
36.27
Earnings Yield % (TTM)
1.36%
Earnings Yield % (FWD)
3.20%
EV / EBITDA (TTM)
43.06
Price / EBITDA (TTM)
46.18
Price / Free Cash Flow (TTM)
62.14
Book Value / Share
$8.05

Company Debt

Total Debt
$1.01B
LT Debt
$1.01B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$1.71B
Debt to Equity
1.18
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$297.31
Close
$297.69
Volume / Avg.
1.26M / 1.11M
Day Range
$293.97 - $302.85
52 Wk Range
283.10 - 495.55
Market Cap
$39.77B
P/E Ratio
73.41
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
5.39%
Days to Cover
5.13

About

Sector
Health Care
Industry
Biotechnology
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi thera...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Alnylam Pharmaceuticals (ALNY) stock?

A

You can purchase shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Alnylam Pharmaceuticals (ALNY) competitors?

A

There are no as such competitors for Alnylam Pharmaceuticals.

Q

What is the forecast, or price target, for Alnylam Pharmaceuticals (ALNY) stock?

A

Alnylam Pharmaceuticals has a consensus price target of $461.00.

Q

What is the current price for Alnylam Pharmaceuticals (ALNY)?

A

The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $298 last updated June 9, 2026 at 6:58 PM EDT.

Q

Does Alnylam Pharmaceuticals (ALNY) pay a dividend?

A

There are no upcoming dividends for Alnylam Pharmaceuticals.

Q

When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?

A

Alnylam Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Alnylam Pharmaceuticals (ALNY) going to split?

A

There is no upcoming split for Alnylam Pharmaceuticals.

Q

What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

A

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.